Integrative Analysis of CD133 mRNA in Human Cancers Based on Data Mining
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrative Analysis of CD133 mRNA in Human Cancers Based on Data Mining
Authors
Keywords
-
Journal
Stem Cell Reviews and Reports
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-15
DOI
10.1007/s12015-018-9865-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pilot Research for the Correlation between the Expression Pattern of E-cadherin-β-Catenin Complex and Lymph Node Metastasis in Early Gastric Cancer
- (2018) Takako Yoshii et al. TUMORI
- Nuclear Localization of Cancer Stem Cell Marker CD133 in Triple-Negative Breast Cancer: A Case Report
- (2018) Monica Cantile et al. TUMORI
- CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy
- (2016) Jian Li et al. BMC CANCER
- Characterizing mutation–expression network relationships in multiple cancers
- (2016) Shila Ghazanfar et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- The epigenetics of tumour initiation: cancer stem cells and their chromatin
- (2016) Alexandra Avgustinova et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Whole-exome sequencing identifies a novel homozygous frameshift mutation in the PROM1 gene as a causative mutation in two patients with sporadic retinitis pigmentosa
- (2016) SANMEI LIU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells
- (2016) M Drachsler et al. Cell Death & Disease
- miR-30 family promotes migratory and invasive abilities in CD133+ pancreatic cancer stem-like cells
- (2016) Koichiro Tsukasa et al. Human Cell
- BMI1,ALDH1A1, andCD133Transcripts Connect Epithelial-Mesenchymal Transition to Cancer Stem Cells in Lung Carcinoma
- (2016) Ana Koren et al. Stem Cells International
- New Insights into the Crossroads between EMT and Stemness in the Context of Cancer
- (2016) Isabel Fabregat et al. Journal of Clinical Medicine
- Recent Advances and Emerging Applications in Text and Data Mining for Biomedical Discovery
- (2015) Graciela H. Gonzalez et al. BRIEFINGS IN BIOINFORMATICS
- Association of CD133 polymorphisms and response to bevacizumab in patients with metastatic colorectal cancer
- (2015) G. Aravantinos et al. Cancer Biomarkers
- Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes
- (2015) Raheleh Roudi et al. CANCER INVESTIGATION
- Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases
- (2015) FEIFENG JING et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133+ pancreatic cancer cells
- (2015) Koichiro Tsukasa et al. Human Cell
- CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis
- (2015) Li Yiming et al. Oncotarget
- Down-Regulated MAC30 Expression Inhibits Proliferation and Mobility of Human Gastric Cancer Cells
- (2014) Xiao-Yan Xu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- ICAM-2 confers a non-metastatic phenotype in neuroblastoma cells by interaction with α-actinin
- (2014) J M Feduska et al. ONCOGENE
- The prognostic value of CD133 expression in non-small cell lung cancer: a meta-analysis
- (2014) Weimin Wang et al. TUMOR BIOLOGY
- Differential CD133 expression distinguishes malignant from benign papillary lesions of the breast
- (2014) Chih-Hung Lin et al. VIRCHOWS ARCHIV
- Surface Markers of Cancer Stem Cells in Solid Tumors
- (2014) Pu Xia Current Stem Cell Research & Therapy
- A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 expression
- (2013) M. Cheng et al. CARCINOGENESIS
- TMEM25Is a Candidate Biomarker Methylated and Down-Regulated in Colorectal Cancer
- (2013) Sonja Hrašovec et al. DISEASE MARKERS
- Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer
- (2013) Kousuke Hashimoto et al. Gastric Cancer
- Ovarian cancer stem cells: Are they real and why are they important?
- (2013) Monjri M. Shah et al. GYNECOLOGIC ONCOLOGY
- Cancer Digital Slide Archive: an informatics resource to support integrated in silico analysis of TCGA pathology data
- (2013) David A Gutman et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells
- (2013) M Takahashi et al. LEUKEMIA
- Polymorphisms at the microRNA binding-site of the stem cell marker geneCD133modify susceptibility to and survival of gastric cancer
- (2013) Qiming Wang et al. MOLECULAR CARCINOGENESIS
- Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma
- (2013) FEI ZHOU et al. Oncology Letters
- Visualizing multidimensional cancer genomics data
- (2013) Michael P Schroeder et al. Genome Medicine
- Abnormal accumulation of human transmembrane (TMEM)-176A and 176B proteins is associated with cancer pathology
- (2012) Math P. Cuajungco et al. ACTA HISTOCHEMICA
- Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
- (2012) Balázs Győrffy et al. ENDOCRINE-RELATED CANCER
- Distinctive expression of CD133 between intraductal papillary neoplasms of the bile duct and bile duct adenocarcinomas
- (2012) Izuru Ohtsubo et al. HEPATOLOGY RESEARCH
- Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy
- (2012) A Pohl et al. PHARMACOGENOMICS JOURNAL
- CD133+CD34+ and CD133+CD38+ blood progenitor cells as predictors of platelet engraftment in patients undergoing autologous peripheral blood stem cell transplantation
- (2012) Alma Y. Camacho Villa et al. TRANSFUSION AND APHERESIS SCIENCE
- Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation
- (2012) Anthony B. Mak et al. Cell Reports
- Genome-Wide Detection of Allele Specific Copy Number Variation Associated with Insulin Resistance in African Americans from the HyperGEN Study
- (2011) Marguerite R. Irvin et al. PLoS One
- Differential Hematopoietic Supportive Potential and Gene Expression of Stroma Cell Lines from Midgestation Mouse Placenta and Adult Bone Marrow
- (2010) Yingchun Wang et al. CELL TRANSPLANTATION
- The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastasis.
- (2010) Jolanta Czyzewska et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Germline copy number variations in BRCA1-associated ovarian cancer patients
- (2010) Kosuke Yoshihara et al. GENES CHROMOSOMES & CANCER
- Integrative analysis of the melanoma transcriptome
- (2010) M. F. Berger et al. GENOME RESEARCH
- Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma
- (2010) Sasaki ONCOLOGY REPORTS
- Module networks revisited: computational assessment and prioritization of model predictions
- (2009) A. Joshi et al. BIOINFORMATICS
- CD133 Expression Pattern Distinguishes Intraductal Papillary Mucinous Neoplasms From Ductal Adenocarcinomas of the Pancreas
- (2009) Kazuya Shimizu et al. PANCREAS
- Common Genetic Variation and the Control of HIV-1 in Humans
- (2009) Jacques Fellay et al. PLoS Genetics
- A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
- (2008) T. Bonome et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More